SG11202004725PA - Protein purification and virus inactivation with alkyl glycosides - Google Patents
Protein purification and virus inactivation with alkyl glycosidesInfo
- Publication number
- SG11202004725PA SG11202004725PA SG11202004725PA SG11202004725PA SG11202004725PA SG 11202004725P A SG11202004725P A SG 11202004725PA SG 11202004725P A SG11202004725P A SG 11202004725PA SG 11202004725P A SG11202004725P A SG 11202004725PA SG 11202004725P A SG11202004725P A SG 11202004725PA
- Authority
- SG
- Singapore
- Prior art keywords
- protein purification
- virus inactivation
- alkyl glycosides
- glycosides
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
- A61L2202/20—Targets to be treated
- A61L2202/21—Pharmaceuticals, e.g. medicaments, artificial body parts
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP17208630 | 2017-12-19 | ||
PCT/EP2018/085735 WO2019121846A1 (en) | 2017-12-19 | 2018-12-19 | Protein purification and virus inactivation with alkyl glycosides |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202004725PA true SG11202004725PA (en) | 2020-07-29 |
Family
ID=60888188
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202004725PA SG11202004725PA (en) | 2017-12-19 | 2018-12-19 | Protein purification and virus inactivation with alkyl glycosides |
Country Status (11)
Country | Link |
---|---|
US (1) | US11479578B2 (pt) |
EP (2) | EP4368210A3 (pt) |
JP (1) | JP7458980B2 (pt) |
KR (1) | KR20200100771A (pt) |
CN (1) | CN111511756B (pt) |
AU (1) | AU2018390797A1 (pt) |
BR (1) | BR112020010760A2 (pt) |
CA (1) | CA3085885A1 (pt) |
DK (1) | DK3728287T3 (pt) |
SG (1) | SG11202004725PA (pt) |
WO (1) | WO2019121846A1 (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2020401034B2 (en) * | 2019-12-12 | 2024-08-29 | Eli Lilly And Company | Methods for viral inactivation by environmentally compatible detergents |
CN111110876A (zh) * | 2020-01-20 | 2020-05-08 | 华兰生物工程重庆有限公司 | 一种特异性人免疫球蛋白病毒灭活工艺 |
CA3212813A1 (en) * | 2021-03-09 | 2022-09-15 | Jcr Pharmaceuticals Co., Ltd. | Method for producing antibody-lysosomal enzyme fusion protein |
KR20240125949A (ko) * | 2021-12-16 | 2024-08-20 | 브리스톨-마이어스 스큅 컴퍼니 | 바이러스 불활성화를 위한 세제 |
TW202403043A (zh) | 2022-03-18 | 2024-01-16 | 美商健臻公司 | 重組人類酸性鞘磷脂酶醫藥組合物及方法 |
CN117866038B (zh) * | 2024-03-11 | 2024-05-28 | 北京百力格生物科技有限公司 | 纯化含有宿主核酸的带亲和标签的酸性蛋白的方法 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5759855A (en) | 1988-09-14 | 1998-06-02 | La Jolla Cancer Research Foundation | Methods for modifying the binding activity of cell adhesion receptors |
EP0531639B1 (en) * | 1991-07-18 | 1999-09-01 | F. Hoffmann-La Roche Ag | Tocopherol cyclase |
EP0714306B1 (en) * | 1993-08-06 | 1998-03-25 | Connaught Laboratories Limited | Inactivated respiratory syncytial viral vaccines |
DE19528221C2 (de) | 1995-08-01 | 1998-10-22 | Blutspendedienst Der Drk Lande | Verfahren zur Herstellung eines virussicheren, therapeutischen Präparates aus Humanplasma |
AU1583397A (en) * | 1996-01-30 | 1997-08-22 | Brigham And Women's Hospital | Antibodies for modulating cd47-mediated neutrophil transmigration |
JP2000500660A (ja) | 1996-07-12 | 2000-01-25 | シェーリング コーポレイション | 哺乳動物TNF―αコンベルターゼ |
AT405939B (de) * | 1997-02-24 | 1999-12-27 | Immuno Ag | Verfahren zur inaktivierung von lipidumhüllten viren |
AU2008200700C1 (en) * | 1997-04-15 | 2013-04-04 | Daiichi Sankyo Co., Ltd | Novel Protein and Process for Producing The Same |
US6610316B2 (en) * | 1997-05-30 | 2003-08-26 | Shanbrom Technologies, Llc | Disinfection by particle-bound and insolubilized detergents |
SE9904803D0 (sv) | 1999-12-27 | 1999-12-27 | Amersham Pharm Biotech Ab | Method for the isolation of hydrophobic proteins |
ATE494909T1 (de) * | 2002-11-20 | 2011-01-15 | Bestewil Holding Bv | Zusammensetzungen mit antigen-komplexen,verfahren zu ihrer herstellung und verfahren zur verwendung derantigen-komplexe zur vakzinierung |
US20100216161A1 (en) | 2009-02-26 | 2010-08-26 | Vertex Pharmaceuticals Incorporated | Method for identifying protease inhibitors |
AU2015252110A1 (en) * | 2009-12-18 | 2015-11-26 | Csl Limited | Method of purifying polypeptides |
AU2010202125B1 (en) * | 2010-05-26 | 2010-09-02 | Takeda Pharmaceutical Company Limited | A method to produce an immunoglobulin preparation with improved yield |
AU2015204304B2 (en) | 2010-12-15 | 2016-04-07 | Takeda Pharmaceutical Company Limited | Viral Inactivation Using Improved Solvent-Detergent Method |
MX2014000753A (es) | 2011-07-20 | 2014-05-07 | Abbott Biologicals Bv | Procedimiento para producir antigeno viral y vacunas. |
CN103214566A (zh) * | 2013-03-30 | 2013-07-24 | 福州新北生化工业有限公司 | 一种g因子的分离纯化方法 |
RU2707951C1 (ru) * | 2013-11-15 | 2019-12-02 | Дженентек, Инк. | Способы инактивации вируса с использованием экологичных детергентов |
DK3297656T3 (da) | 2015-05-22 | 2020-03-09 | CSL Behring Lengnau AG | Trunkeret von Willebrand Faktor polypeptider til behandling af hæmofili |
GB2581882B (en) | 2017-08-01 | 2023-03-29 | Ankasa Regenerative Therapeutics Inc | WNT compositions and methods of process from serum-free culturing conditions |
-
2018
- 2018-12-19 CN CN201880082189.XA patent/CN111511756B/zh active Active
- 2018-12-19 EP EP24159409.2A patent/EP4368210A3/en active Pending
- 2018-12-19 JP JP2020533822A patent/JP7458980B2/ja active Active
- 2018-12-19 EP EP18826000.4A patent/EP3728287B1/en active Active
- 2018-12-19 DK DK18826000.4T patent/DK3728287T3/da active
- 2018-12-19 WO PCT/EP2018/085735 patent/WO2019121846A1/en unknown
- 2018-12-19 US US16/955,172 patent/US11479578B2/en active Active
- 2018-12-19 CA CA3085885A patent/CA3085885A1/en active Pending
- 2018-12-19 KR KR1020207020960A patent/KR20200100771A/ko not_active Application Discontinuation
- 2018-12-19 SG SG11202004725PA patent/SG11202004725PA/en unknown
- 2018-12-19 AU AU2018390797A patent/AU2018390797A1/en active Pending
- 2018-12-19 BR BR112020010760-3A patent/BR112020010760A2/pt unknown
Also Published As
Publication number | Publication date |
---|---|
JP2021506875A (ja) | 2021-02-22 |
KR20200100771A (ko) | 2020-08-26 |
EP4368210A2 (en) | 2024-05-15 |
CN111511756A (zh) | 2020-08-07 |
CN111511756B (zh) | 2023-11-03 |
US11479578B2 (en) | 2022-10-25 |
EP4368210A3 (en) | 2024-07-24 |
WO2019121846A1 (en) | 2019-06-27 |
EP3728287B1 (en) | 2024-04-10 |
DK3728287T3 (da) | 2024-06-10 |
BR112020010760A2 (pt) | 2020-11-17 |
AU2018390797A1 (en) | 2020-07-02 |
EP3728287A1 (en) | 2020-10-28 |
US20200317727A1 (en) | 2020-10-08 |
JP7458980B2 (ja) | 2024-04-01 |
CA3085885A1 (en) | 2019-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL273432A (en) | Protein compounds and their uses | |
SG11202004725PA (en) | Protein purification and virus inactivation with alkyl glycosides | |
ZA201900278B (en) | Variant adeno-associated viruses and methods of using | |
IL268346A (en) | Targeted chimeric proteins and their uses | |
IL267949A (en) | A modified virus | |
EP3277819A4 (en) | Adeno-associated virus variants and methods of use thereof | |
SG11202006232SA (en) | Adeno-associated virus purification methods | |
HK1231402A1 (zh) | 治療 型肝炎和 型肝炎病毒感染的方法 | |
EP3309251A4 (en) | VIRAL VECTOR OF PARAINFLUENZA TYPE 2 HUMAN AND VACCINE | |
EP3284344A4 (en) | Purification device and aquarium comprising same | |
EP3518947C0 (en) | OPTIMIZED ONCOLYTIC VIRUSES AND USES THEREOF | |
GB201711481D0 (en) | Protein purification | |
IL267639A (en) | Oncolytic viruses and therapeutic molecules | |
HK1253377A1 (zh) | 可編程的溶瘤病毒疫苗系統及其應用 | |
HK1253557A1 (zh) | 純化和/或病毒滅活的方法 | |
HK1252343A1 (zh) | 用於治療病毒感染的組合物和方法 | |
EP3166637A4 (en) | Compositions and methods for treating dengue virus infection | |
ZA202002069B (en) | Novel mek-inhibitor for the treatment of viral and bacterial infections | |
EP3268034A4 (en) | Non-neuroinvasive viruses and uses thereof | |
EP3569687A4 (en) | VIRUS INACTIVATION KIT AND VIRUS INACTIVATION DEVICE | |
GB201503579D0 (en) | Limb support and limb support fastening arrangement | |
IL273229A (en) | Methods for inactivating viruses using N-methylglucamide and its history | |
GB201706600D0 (en) | Virus preparations | |
GB201617487D0 (en) | Reducing viral infection and/or viral reactivation during immunotherapy | |
GB201520957D0 (en) | Reducing viral infection and/or viral reactivation during immunotherapy |